Found: 18
Select item for more details and to access through your institution.
Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease.
- Published in:
- Allergy, 2021, v. 76, n. 6, p. 1861, doi. 10.1111/all.14661
- By:
- Publication type:
- Article
An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cells.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 9, p. 932, doi. 10.1111/1440-1681.12784
- By:
- Publication type:
- Article
Airway and Systemic Immune Responses Following the Third COVID-19 Vaccination in COPD Patients.
- Published in:
- International Journal of COPD, 2023, v. 18, p. 3027, doi. 10.2147/COPD.S433269
- By:
- Publication type:
- Article
The dose response of inhaled LPS challenge in healthy subjects.
- Published in:
- European Journal of Inflammation, 2018, v. 16, p. 1, doi. 10.1177/2058739218784820
- By:
- Publication type:
- Article
The effects of corticosteroids on COPD lung macrophages: a pooled analysis.
- Published in:
- Respiratory Research, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12931-015-0260-0
- By:
- Publication type:
- Article
The effects of corticosteroids on COPD lung macrophages: a pooled analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The stability of blood Eosinophils in chronic obstructive pulmonary disease.
- Published in:
- 2020
- By:
- Publication type:
- letter
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge.
- Published in:
- Biomarker Research, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40364-018-0128-9
- By:
- Publication type:
- Article
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 5, p. 767, doi. 10.1111/bcp.12546
- By:
- Publication type:
- Article
High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 3, p. 523, doi. 10.1111/bcp.12508
- By:
- Publication type:
- Article
Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
- Published in:
- 2017
- By:
- Publication type:
- letter
Anti-inflammatory potential of PI3Kδ and JAK inhibitors in asthma patients.
- Published in:
- Respiratory Research, 2016, v. 17, p. 1, doi. 10.1186/s12931-016-0436-2
- By:
- Publication type:
- Article
Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081949
- By:
- Publication type:
- Article
Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis.
- Published in:
- Clinical Pharmacology, 2019, v. 11, p. 67, doi. 10.2147/CPAA.S184404
- By:
- Publication type:
- Article
CRTH2 antagonists in asthma: current perspectives.
- Published in:
- Clinical Pharmacology, 2017, v. 9, p. 165, doi. 10.2147/CPAA.S119295
- By:
- Publication type:
- Article
Reduced exhaled breath condensate pH in asthmatic smokers using inhaled corticosteroids.
- Published in:
- Respirology, 2009, v. 14, n. 3, p. 419, doi. 10.1111/j.1440-1843.2009.01492.x
- By:
- Publication type:
- Article
The relationship between airway immunoglobulin activity and eosinophils in COPD.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 4, p. 2203, doi. 10.1111/jcmm.16206
- By:
- Publication type:
- Article
Type‐2 airway inflammation in mild asthma patients with high blood eosinophils and high fractional exhaled nitric oxide.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1259, doi. 10.1111/cts.13078
- By:
- Publication type:
- Article